The prevalence of anemia (defined as hemoglobin [Hb] < 11 g/dL) in patients with lung cancer ranges from 50% to 60%, and blood transfusions are common, with 30% to 40% of patients requiring this treatment [6,7]. This evidence concerns the gene GSTM1 and lung cancer.